Search

Search Constraints

You searched for: Author/Creator Dierssen, Mara

Search Results

1. A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome. Issue 2 (February 2020)

2. AGC1‐malate aspartate shuttle activity is critical for dopamine handling in the nigrostriatal pathway. (7th January 2013)

3. Anomalous brain functional connectivity contributing to poor adaptive behavior in Down syndrome. (March 2015)

5. Cognition and Hippocampal Plasticity in the Mouse Is Altered by Monosomy of a Genomic Region Implicated in Down Syndrome. Issue 3 (1st July 2014)

8. Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Issue 2 (14th September 2013)